ARTMS to Advance ImmunoPET Imaging Isotope with Funding Support from Innovate BC

03 Mar, 2021

ARTMS to Advance ImmunoPET Imaging Isotope with Funding Support from Innovate BC
Photo by Marten Bjork on Unsplash

– ARTMS received $300,000 funding from Innovate BC.
– The funding will be combined with over $600,000 from additional sources to further develop and validate the production of Zr-89 for use in Positron Emission Tomography (PET) imaging scans of cancer patients eligible for immuno-oncology (IO) therapies.
– “We’re excited to help accelerate game-changing innovation like ARTMS’ proprietary approach to producing critically important, high-quality radiopharmaceutical medical isotopes for cancer patients,” said Mr. Raghwa Gopal, President/CEO of Innovate BC.
– “Past winners have solved critical market problems that other companies have tried to solve for 50 years.”

Health Care Information Technology North America
Crunchbase icon

Content report

The following text will be sent to our editors: